Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

As of 7 February at 12:23:18 pm GMT-5. Market open.

As of February 6 at 1:58:05 p.m. EST. Market Open.

As of February 5 at 11:51:34 a.m. EST. Market Open.

As of 5 February at 11:51:34 am GMT-5. Market open.

As of February 7 at 3:59:13 PM EST. Market Open.

Ringing Bells Freedom 251 mobile was launched in February 2016. The phone comes with a 4.00-inch touchscreen display offering a resolution of 540x960 pixels. Ringing Bells Freedom 251 is powered by a ...

As of 14:21:18 GMT-5. Market open.

At close: 6 February at 3:45:08 pm GMT-5 ...